Literature DB >> 9557938

Culture of human main pancreatic duct epithelial cells.

D Oda1, C E Savard, T D Nguyen, E R Swenson, S P Lee.   

Abstract

Attempts to grow human pancreatic duct epithelial cells in long-term culture have proven difficult. We have developed a system of growing these cells for several passages by adapting methods used to culture dog pancreatic duct cells. Epithelial cells were enzymatically dissociated from the main pancreatic duct and plated onto collagen-coated culture inserts suspended above a human fibroblast feeder layer. After primary culture, the cells were either passaged onto new inserts or plastic tissue culture plates in the absence of collagen. Cells grown on the latter plates were maintained in a serum-free medium. Primary pancreatic duct epithelial cells grow steadily to confluence as a monolayer in the feeder layer system. After primary culture, cells passaged onto new inserts with fresh feeder layer or plastic plates and fed with serum-free medium continued to develop into confluent monolayers for up to four passages. The cells were columnar with prominent apical microvilli, sub-apical secretory vesicles, and lateral intercellular junctions resembling the morphology of normal in vivo epithelial cells. These cells were also positive for cytokeratin 19, 7, and 8 and carbonic anhydrase II, as measured by immunohistochemistry. Metabolically, these cells synthesized and secreted mucin, as measured by incorporation of tritiated N-acetyl-D-glucosamine. In conclusion, we demonstrated that human pancreatic epithelial cells from the main duct can be successfully grown in culture and repeatedly passaged using a feeder layer system, with serum-free medium, and in organotypic cultures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557938     DOI: 10.1007/s11626-998-0126-6

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  37 in total

1.  Normal human pancreas cultures display functional ductal characteristics.

Authors:  M R Vila; J Lloreta; F X Real
Journal:  Lab Invest       Date:  1994-09       Impact factor: 5.662

2.  The effect of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) on cultured dog pancreatic duct epithelial cells.

Authors:  D Oda; C E Savard; L Eng; S P Lee
Journal:  Pancreas       Date:  1996-03       Impact factor: 3.327

3.  Dog pancreatic duct epithelial cells: long-term culture and characterization.

Authors:  D Oda; C E Savard; T D Nguyen; L Eng; E R Swenson; S P Lee
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 4.  Pancreatic duct cell cultures.

Authors:  S Githens
Journal:  Annu Rev Physiol       Date:  1994       Impact factor: 19.318

5.  Neoplastic transformation of propagable cultured rat pancreatic duct epithelial cells by azaserine and streptozotocin.

Authors:  J G Shepherd; J R Chen; M S Tsao; W P Duguid
Journal:  Carcinogenesis       Date:  1993-05       Impact factor: 4.944

6.  Isolation, culture, and characterization of human pancreatic duct cells.

Authors:  B Trautmann; H J Schlitt; E G Hahn; M Löhr
Journal:  Pancreas       Date:  1993-03       Impact factor: 3.327

7.  Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma.

Authors:  R T Morgan; L K Woods; G E Moore; L A Quinn; L McGavran; S G Gordon
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

Review 8.  Models of pancreatic cancer.

Authors:  P A Hall; N R Lemoine
Journal:  Cancer Surv       Date:  1993

9.  Expression and characterization of alkaline phosphatases during differentiation of human pancreatic cancer (Capan-1) cells in culture.

Authors:  M Fanjul; M Thèveniau; C Palévody; G Rougon; E Hollande
Journal:  Biol Cell       Date:  1991       Impact factor: 4.458

10.  Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies.

Authors:  A M Gown; A M Vogel
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

View more
  8 in total

1.  Primary culture of avian pancreatic acinar cells for heterologous gene expression.

Authors:  J Hall; I R Jowsey; B Brown
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  In vitro models of pancreatic cancer for translational oncology research.

Authors:  Georg Feldmann; Sherri Rauenzahn; Anirban Maitra
Journal:  Expert Opin Drug Discov       Date:  2009-04-01       Impact factor: 6.098

3.  Reconstituted human oral and esophageal mucosa in culture.

Authors:  D Oda; C E Savard; L Eng; J Sekijima; G Haigh; S P Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

4.  Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional Culture.

Authors:  Yoshihisa Matsushita; Barbara Smith; Michael Delannoy; Maria A Trujillo; Peter Chianchiano; Ross McMillan; Hirohiko Kamiyama; Hong Liang; Elizabeth D Thompson; Ralph H Hruban; William Matsui; Laura D Wood; Nicholas J Roberts; James R Eshleman
Journal:  Pancreas       Date:  2019-10       Impact factor: 3.327

5.  Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype.

Authors:  H Ouyang; Lj Mou; C Luk; N Liu; J Karaskova; J Squire; M S Tsao
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

6.  The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.

Authors:  Bo Chen; Qinhua Li; Yongping Zhou; Xujing Wang; Qiqi Zhang; Yongkun Wang; Huiren Zhuang; Xiaohua Jiang; Wujun Xiong
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

7.  Gene expression patterns in pancreatic tumors, cells and tissues.

Authors:  Anson W Lowe; Mari Olsen; Ying Hao; Sum P Lee; Kyu Taek Lee; Xin Chen; Matt van de Rijn; Patrick O Brown
Journal:  PLoS One       Date:  2007-03-28       Impact factor: 3.240

8.  MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.

Authors:  Chunyou Wang; Pian Liu; Heshui Wu; Pengfei Cui; Yongfeng Li; Yao Liu; Zhiqiang Liu; Shanmiao Gou
Journal:  Oncotarget       Date:  2016-03-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.